Skip to main content
. 2020 May 20;10:8307. doi: 10.1038/s41598-020-57647-x

Table 3.

Linear models of anxiety/depression at T1 and change in anxiety/depression over time predicting the EQ-5D summary index at T2 (Model 1 and 2); and of the EQ-5D summary index at T1 and change in the summary index over time predicting anxiety/depression at T2 (Model 3 and 4).

Crude model Adjusted model for baseline outcome * Adjusted model for baseline outcome and confounders # Adjusted R2
Β (SE) P Β (SE) P Β (SE) P
Outcome: EQ-5D Index at T2
Model 1 Predictor Anxiety at T1 −0.03 (0.01) <0.001 0.00 (0.01) 0.949 −0.01 (0.01) 0.121 0.467
Change in Anxiety −0.01 (0.01) 0.132 −0.02 (0.01) <0.001 −0.03 (0.01) <0.001
Model 2 Predictor Depression at T1 −0.03 (0.01) <0.001 0.00 (0.01) 0.477 −0.02 (0.01) 0.025 0.561
Change in Depression −0.02 (0.01) 0.014 −0.02 (0.00) <0.001 −0.03 (0.01) <0.001
Outcome: Anxiety at T2
Model 3 Predictor EQ-5D Index at T1 −9.49 (1.35) <0.001 −1.55 (1.39) 0.263 −3.14 (1.74) 0.072 0.707
Change in EQ-5D Index −0.04 (2.04) 0.986 −4.78 (1.36) <0.001 −6.50 (1.46) <0.001
Outcome: Depression at T2
Model 4 Predictor EQ-5D Index at T1 −12.4 (1.19) <0.001 −6.65 (1.64) <0.001 −7.43 (1.87) <0.001 0.720
Change in EQ-5D Index 0.52 (2.12) 0.807 −4.07 (1.51) 0.007 −7.24 (1.43) <0.001

Note: B, standardized coefficient; SE, standard error; EQ-5D, the European Quality of Life at five dimensions; Higher score on EQ-5D index indicate better quality of life in mobility, self-care, usual activities, pain/discomfort and anxiety/depression, while higher scores on anxiety and depression subscales indicates more anxiety/depression symptoms. *Interactions between baseline outcome and predictor were excluded in the model, as no statistically significant interactions were found (P > 0.05). #Model adjusted for demographic and diabetes characteristics, including gender, age, diabetes type, diabetes duration, employment status, education level, ethnicity; both of the baseline predictor and change in predictor were included in the model.